back to Meetings page
  • IMMPACT-XI
  • June 5-6, 2009
  • Ritz Carlton Pentagon City
  • Arlington, Virginia

  • Co-chairs:
  • Dennis C. Turk, PhD (University of Washington)
  • Robert H. Dworkin, PhD (University of Rochester)
  • Academia and Related Participants
  • Michael A. Ashburn, MD (University of Pennsylvania)
  • John T. Farrar, MD, PhD (University of Pennsylvania)
  • Roger B. Fillingim, PhD (University of Florida)
  • Ian Gilron, MD (Queen's University)
  • Joel Katz, PhD (York University)
  • Henrik Kehlet, MD, PhD (Copenhagen University)
  • John D. Markman, MD (University of Rochester)
  • Michael P. McDermott, PhD (University of Rochester)
  • Anne Louise Oaklander, MD, PhD (Harvard University)
  • Sarah Peirce-Sandner, MS (University of Rochester)
  • Michael J. Polydefkis, MD (Johns Hopkins University)
  • Srinivasa N. Raja, MD (Johns Hopkins University)
  • James P. Robinson, MD, PhD (University of Washington)
  • Gary A. Walco, PhD (University of Washington)
  • Clifford J. Woolf, MB, PhD (Harvard University)
  • Dan Ziegler, MD (Heinrich Heine University)
  • Government Participants
  • Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
  • Igor Cerny, PharmD (US Food and Drug Administration)
  • Ann Costello, DMD, PhD (US Food and Drug Administration)
  • Linda Porter, PhD (National Institute of Health)
  • Bob A. Rappaport, MD (US Food and Drug Administration)
  • Patient Representative
  • Penney Cowan (American Chronic Pain Association)
  • Industry Participants
  • Veeraindar Goli, MD (King Pharmaceuticals)
  • Ole X. Graff, MD (GlaxoSmithKline)
  • Smriti Iyengar, PhD (Eli Lilly & Company)
  • Gary W. Jay, MD (Pfizer)
  • Ernest Kopecky, PhD (Endo Pharmaceuticals)
  • Richard Malamut, PhD (AstraZeneca Pharmaceuticals)
  • Pamela Palmer, MD (AcelRx)
  • Christine Rauschkolb, MD, PhD (Johnson & Johnson)
  • Ilona Steigerwald, MD (Grunenthal GmbH)
  • Jeffrey Tobias, MD (NeurogesX, Inc.)